Topics
- #Quality (1)
- ACCURUN (1)
- AMR (1)
- anti-fluor (1)
- Antigens & Antibodies (11)
- Beginners (2)
- biochemistry (1)
- BRCA (1)
- Calibration Verification (4)
- cancer (1)
- Carrier Screening (1)
- Case Study (1)
- CLIA (2)
- clinical genomics (8)
- Clinical Significance (1)
- CNV (1)
- COVID-19 (1)
- ctDNA (1)
- Dengue Virus (1)
- DPYD (1)
- Flaviviruses (1)
- Genomic Testing (1)
- Hendra (1)
- HEV (1)
- HIV (1)
- HRD (1)
- Immuno-Oncology (1)
- Influenza (2)
- Inherited (1)
- ISO 15189 (2)
- KPL (1)
- liquid biopsy (1)
- lymphoma (1)
- Methylated DNA (3)
- Molecular Diagnostics (10)
- Mpox (1)
- NGS (12)
- Nipah (1)
- NIPT (2)
- PGT-A (1)
- Pharmacogenetics (1)
- prostate (1)
- QC Procedures (2)
- QC Regulation (1)
- Quality Control (4)
- Reagent Components (1)
- Reportable Range (1)
- Reproductive Health (1)
- SARS-CoV-2 (1)
- Serology (2)
- sexually transmitted diseases (1)
- STD (1)
- Tick-Borne Disease (2)
- TORCH (1)
- troubleshooting (1)
- VALIDATE (1)
- VLP (1)
- Webinar (1)
Subscribe to this blog by filling out the form below!
Posts about
clinical genomics
Ideal Samples for Validating Next-Generation Sequencing-Based Plasma Circulating Tumor DNA Assays
Over the past decade, liquid biopsy-based testing, especially using next-generation sequencing...
5 minute read
Copy That! Detecting Copy Number Variation in Disease Using Next Generation Sequencing
If one of your colleagues suggests including copy number variations (CNVs) in your assay that...
4 minute read
How to get the most from your Seraseq® FFPE Reference Materials
Most tumor profiling assay workflows use tissue biopsy samples that are formalin fixed and paraffin...
5 minute read
Continued Advances in NIPT Drives Updated Recommendations
Our 2020 blog, Evolution of non-invasive prenatal testing (NIPT), discussed the testing’s history...
4 minute read
When a Bad Repair Leads to a Happy Ending: Homologous Recombination Deficiency Assays for Guiding Anti-Cancer Therapies
Genome instability - in which tumor cells sustain elevated frequencies of chromosomal lesions - is...
6 minute read
Optimal Reference Materials for Evolving Oncology Testing
Targeted therapies are dramatically improving cancer treatment. Next-generation sequencing (NGS)...
2 minute read
Are your BRCA1/2 tests sufficient?
Breast cancer susceptibility genes 1 and 2 (BRCA1 and BRCA2) encode proteins functioning as tumor...
4 minute read